stella
beta
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT — Stella
Recruiting
Back to Breast Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Shengjing Hospital of China Medical University, Shenyang, Liaoning
View full record on ClinicalTrials.gov